HighTower Advisors
VTAK icon

HighTower Advisors’s Catheter Precision VTAK Stock Holding History

HighTower Advisors’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2
Closed -$6K – 3422
2022
Q2 		$6K Hold
2
– – ﹤0.01% 3113
2022
Q1 		$8K Buy
+2
New +$13.6K ﹤0.01% 3235
2020
Q4 		– Hold
0
– -$4K – 2880
2020
Q3 		– Hold
0
– – – 2476

Other funds holding VTAK

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $3.64B AUM 14.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HighTower Advisors's VTAK Position: Q3 2022 in Review

HighTower Advisors sold out of Catheter Precision (VTAK) in Q3 2022, closing a stake of 2 shares — an estimated $6K sold.

HighTower Advisors first reported a position in VTAK in Q1 2022 and held it in 2 quarters. The position peaked at $8K in Q1 2022. 17 funds tracked by Wall St. Rank hold VTAK as of Q3 2022.

  • HighTower Advisors reported no remaining Catheter Precision position as of Q3 2022 after selling out during the quarter.
  • HighTower Advisors sold 2 Catheter Precision shares in Q3 2022, an estimated $6K.
  • HighTower Advisors first reported a position in Catheter Precision in Q1 2022 and held it in 2 quarters.
  • HighTower Advisors's Catheter Precision position peaked at $8K in Q1 2022.
  • 17 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2022.

Based on HighTower Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.